Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amag Pharmaceuticals (NQ: AMAG )

13.75 USD UNCHANGED
Last Price Updated: 4:06 PM EST, Nov 13, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Amag Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
AMAG Pharmaceuticals and Palatin Technologies Enter Into Exclusive Licensing Agreement for North American Rights to Rekyndatm (bremelanotide), a Potential Treatment for a Common Female Sexual Disorder
AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) together with Palatin Technologies, Inc. (NYSE MKT:PTN) today announced they have entered into an agreement for exclusive North American rights to develop and... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, chief executive officer, will present at the 35th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017 at... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Announces Appointment of Brian Kelley to Board of Directors
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that Brian Kelley, former president and chief executive officer of Keurig Green Mountain, Inc. has been elected to AMAG’s board of directors,... 
From GlobeNewswire News Releases
Diagnostic Substances Stocks on Investors' Radar -- Palatin Technologies, AMAG Pharma, Nymox Pharma, and IDEXX Laboratories
From PR Newswire
AMAG Pharmaceuticals Doubles Support of Prematurity Prevention Research
Grant awards in 2016 support promising research aimed at improving the health of mothers and babies 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today reported unaudited consolidated financial results for the third quarter ended September 30, 2016. Total revenue for the third quarter of 2016 increased... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in the following investor conferences: 
From GlobeNewswire News Releases
AMAG Pharmaceuticals to Host Third Quarter 2016 Financial Results Conference Call and Webcast on Thursday, November 3, 2016 at 8:00 a.m. ET
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that its third quarter 2016 financial results will be released on Thursday, November 3, 2016 before the U.S. financial markets open. At 8:00... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Announces Achievement of Key Milestones in Next Generation Development Programs for Makena® and Feraheme®
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that it has achieved two key milestones in its next generation development programs. The definitive pharmacokinetic study and the comparative... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Appoints Tony Casciano as Senior Vice President of Hematology/Oncology Sales and Marketing
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today the appointment of Tony Casciano to senior vice president of sales and marketing for the company’s Hematology and Oncology business. He will... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals to Present at Upcoming Investor Conference
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in an analyst-led fireside chat at the Morgan Stanley Global Healthcare Conference on Monday, September... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today reported unaudited consolidated financial results for the second quarter ended June 30, 2016. Total product and service revenues for the second quarter of... 
From GlobeNewswire News Releases
How These Healthcare Stocks are Performing? -- AMAG Pharma, IDEXX Laboratories, Neogenomics, and ICON
From PR Newswire
AMAG Pharmaceuticals to Host Conference Call on August 9, 2016 at 8:00 a.m. ET to Discuss Financial Results for the Second Quarter Ended June 30, 2016
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it will report unaudited consolidated financial results for the second quarter ended June 30, 2016 before the U.S. financial markets open on... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals CEO William Heiden Elected to PhRMA Board of Directors
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, chief executive officer (CEO), has been named to the Board of Directors of the Pharmaceutical Research and Manufacturers of... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Appoints Mark Stanton as Vice President, Market Access & Corporate Accounts
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Mark Stanton to the newly created position of vice president, market access and corporate accounts. In this role, Mr. Stanton... 
From GlobeNewswire News Releases
Healthcare Sector Equities Under the Scanner - Alkermes, AMAG Pharma, IDEXX Laboratories, and Aduro BioTech
From PR Newswire
Collegium Announces Election of John A. Fallon, M.D. to Board of Directors
Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced the election of John A. Fallon, M.D. to the Board of Directors. 
From GlobeNewswire News Releases
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will discuss AMAG’s business and financial outlook, strategy and growth prospects at the following investor conferences... 
From GlobeNewswire News Releases
Why Investors Still See Value in Alkermes, AMAG Pharmaceuticals, IDEXX Laboratories and Atossa Genetics?
From PR Newswire
AMAG Pharmaceuticals Announces 2016 Analyst Day
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), a specialty pharmaceutical company with a diverse portfolio of products in the areas of maternal health, anemia management and cancer supportive care, today... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Reports First Quarter 2016 Financial Results
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), a specialty pharmaceutical company with a diverse portfolio of products in the areas of maternal health, anemia management and cancer supportive care, today... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals to Participate in the Deutsche Bank 41st Annual Healthcare Conference
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that management will participate in an analyst-led fireside chat at the Deutsche Bank 41st Annual Healthcare Conference on Wednesday, May 4,... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals to Host Conference Call on May 3, 2016 at 8:00 a.m. ET to Discuss Financial Results for the First Quarter Ended March 31, 2016
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it will report unaudited consolidated financial results for the first quarter ended March 31, 2016 before the U.S. financial markets open on... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Appoints Edward Myles as Chief Financial Officer
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Edward (Ted) Myles as senior vice president, chief financial officer and treasurer of AMAG. In this position, Mr. Myles will... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals to Participate in 15th Annual Needham Healthcare Conference
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that management will participate in the 15th Annual Needham Healthcare Conference in New York City. The company is scheduled to present on... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Announces the U.S. Commercial Launch of New Single-Dose, Preservative-Free Makena® (hydroxyprogesterone caproate injection)
Company also Announces Expansion of Home Healthcare Support through Makena Care Connection 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Announces First Patient Enrolled in Head-to-Head Phase 3 Clinical Trial Evaluating Feraheme® in Adults With Iron Deficiency Anemia
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that it has enrolled the first patient in the head-to-head, Phase 3 clinical trial evaluating the safety of Feraheme® (ferumoxytol) compared to... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will discuss AMAG’s business and financial outlook, strategy and growth prospects at the following investor conferences... 
From GlobeNewswire News Releases
Snyder's-Lance Set to Join the S&P MidCap 400; Trex, AMAG Pharmaceuticals to Join S&P SmallCap 600
S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices: 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.